newsfilter
← Latest News
Business Wire·

Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders

Highlights Destruction of Nearly 95% in Stockholder Value Under Chairman and CEO Dr. Paul Wagner's Leadership Exposes Forte's Worst-in-Class Governance and Repeated Attempts to Use Corporate Machinery as an